Purchases and Sales Made in Q1 2022 in Intellia Therapeutics, Inc. (NTLA)
This table provides information about the institutional ownership of Intellia Therapeutics, Inc. (NTLA) during Q1 2022. The information is specifically focused on institutions that hold shares of Intellia Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 13, 2022
Q1 2022
|
Franklin Resources Inc
San Mateo, CA |
SELL
|
- |
-163K- 14.43% |
$9.49M - $19.4M
|
967K
$9.18M
|
|
|
May 13, 2022
Q1 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-228K- 14.98% |
$13.3M - $27.2M
|
1.29M
$12.3M
|
|
|
May 16, 2022
Q1 2022
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-259K- 95.42% |
$15.1M - $30.8M
|
12.4K
$118K
|
|
|
May 16, 2022
Q1 2022
|
Driehaus Capital Management LLC
Chicago, IL |
SELL
|
- |
-274KClosed |
$16M - $32.6M
|
0
$0
|
|
|
May 16, 2022
Q1 2022
|
Holocene Advisors, LP
New York, NY |
SELL
|
- |
-317KClosed |
$18.4M - $37.7M
|
0
$0
|
|
|
May 12, 2023
Q1 2022
|
Norges Bank
Oslo, Q8 |
SELL
|
- |
-356K- 41.58% |
$20.8M - $42.4M
|
501K
$4.76M
|
|
|
May 09, 2022
Q1 2022
|
Norges Bank
Oslo, Q8 |
SELL
|
- |
-442KClosed |
$25.7M - $52.6M
|
0
$0
|
|
|
May 16, 2022
Q1 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-460K- 46.42% |
$26.8M - $54.7M
|
531K
$5.04M
|
|
|
May 16, 2022
Q1 2022
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-547K- 76.17% |
$31.8M - $65M
|
171K
$1.62M
|
|
|
May 13, 2022
Q1 2022
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
SELL
|
- |
-584K- 61.69% |
$34M - $69.5M
|
363K
$3.45M
|
|
|
May 16, 2022
Q1 2022
|
Darwin Global Management, Ltd.
St. Helier, Y9 |
SELL
|
- |
-606KClosed |
$35.3M - $72.1M
|
0
$0
|
|
|
May 11, 2022
Q1 2022
|
Jennison Associates LLC
|
SELL
|
- |
-725K- 70.06% |
$42.3M - $86.3M
|
310K
$2.95M
|